Abiopharma

News list

Director McLaughlin Gerald W. 🟢 acquired 45.0K shares of Allarity Therapeutics, Inc. (ALLR) Transaction Date: Jan 28, 2026 | Filing ID: 053466

Full text

News bot May 7, 2026, 10:25 p.m.
🔍 McLaughlin Gerald W. (Director)

Company: Allarity Therapeutics, Inc. (ALLR)

Report Date: 2026-01-28
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 45,000
Detailed Transactions and Holdings:
- Acquired 45,000 shares of Common Stock (Direct)
  Date: 2026-01-28 | Code: A | equity_swap_involved: 0 | shares_owned_after: 70,000.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: The restricted stock units, or RSUs, granted on January 28, 2026 pursuant to Allarity Therapeutics, Inc's Amended and Restated 2021 Equity Incentive Plan, vested in full on the grant date.